COVID-19 in Sweden
Current COVID-19 activity in Sweden, based on ECDC ERVISS weekly data, set against the parallel flu and RSV trajectories.
This page tracks how much COVID-19 is circulating, not symptoms or diagnosis.
Influenza: Low
Low
The source currently reports no meaningful activity (as of 16 Aug 2026).
Data window: Week 33 · Aug 10 – Aug 16 · Source: ECDC (weekly) · Source on seasonal break, next data from week 40
Get one free alert when the wave turns in Sweden
We write exactly once: the moment the level goes up. No account, no newsletter. We store your address and the country, nothing else. Every mail has a one click unsubscribe. Privacy
View the last 8 weeks
In week 33 of 2026, Influenza activity in Sweden is classified as low.
The source reports no meaningful activity across these weeks; a week-over-week percentage would be pure noise here.
The last 8 reported weeks
| Week | Relative | Level | vs prior week |
|---|---|---|---|
| Week 33 | – | Low | – |
| Week 32 | – | Low | – |
| Week 31 | – | Low | – |
| Week 30 | – | Low | – |
| Week 29 | – | Low | – |
| Week 28 | – | Low | – |
| Week 27 | – | Low | – |
| Week 26 | – | Low | – |
Across these weeks the source reports no meaningful activity, the values sit at the floor of its scale.
Current activity
- InfluenzaLowstableWeek 33Trend: stable · Week 33
- COVID-19LowstableWeek 33Trend: stable · Week 33
- RSVLowstableWeek 33Trend: stable · Week 33
What this means
In week 33 of 2026, activity of COVID-19 in Sweden is low. The trend, derived from clinical surveillance, is stable. Activity has barely shifted over the past few weeks.
Data, context and methodology
The current picture for Sweden is built on the European Respiratory Virus Surveillance Summary (ERVISS), published weekly by the European Centre for Disease Prevention and Control (ECDC). Folkhälsomyndigheten is the national public-health authority that feeds ERVISS with sentinel primary care and virology data. Sweden does not always report ILI consultation rates to ERVISS; when national ILI is missing we fall back to the EU median so the signal remains comparable.
ECDC ERVISS
ERVISS is ECDC's weekly pan-European surveillance summary for influenza, SARS-CoV-2 and RSV. National authorities, in Sweden's case Folkhälsomyndigheten, submit harmonised indicators every week, which ECDC publishes in a standardised dataset on Thursdays. Using ERVISS rather than each country's native portal ensures cross-country comparability.
ILI / ARI consultation rates and positivity
Folkhälsomyndigheten operates a sentinel network of general practices that report weekly rates of patients consulting for influenza-like illness (ILI) or acute respiratory infection (ARI). A subset of patients is swabbed and tested by reference laboratories, producing pathogen-specific positivity rates for flu, SARS-CoV-2 and RSV.
Why this source
Combining consultation incidence with virological positivity yields a pathogen-specific weekly incidence signal (ILI × positivity / 100). This is the standard European methodology and provides a more robust view than either indicator alone: consultation rates capture illness burden, positivity confirms which pathogen is driving it.
Qualitative classification
The “low”, “moderate” and “high” categories follow seasonal reference values and epidemiological thresholds calibrated to match our classifications for other countries. The ILI × positivity / 100 product is scaled to comparable thresholds using a divisor of 3, which aligns European sentinel peaks with the consultation-equivalent scale used elsewhere. Data refreshes weekly when ECDC publishes the latest ERVISS update, typically on Thursdays.
Source and seasonal pattern by pathogen
- Influenza
- The classification is based on the ECDC ERVISS weekly reports, drawing on sentinel and virological data from the Public Health Agency of Sweden (Folkhälsomyndigheten); where national indicators are stale, the EU median is used as a fallback. Seasonally, infection waves in Sweden typically peak between January and March; activity is usually markedly lower during the summer months.
- COVID-19
- The classification is based on the ECDC ERVISS weekly reports, drawing on COVID-19 indicators from the Public Health Agency of Sweden (Folkhälsomyndigheten); where national indicators are stale, the EU median is used as a fallback. Seasonally, infection waves in Sweden typically peak during winter, with occasional summer waves driven by new variants; activity is usually markedly lower in late spring between waves.
- RSV
- The classification is based on the ECDC ERVISS weekly reports, drawing on RSV indicators from the Public Health Agency of Sweden (Folkhälsomyndigheten); where national indicators are stale, the EU median is used as a fallback. Seasonally, infection waves in Sweden typically peak between December and February; activity is usually markedly lower in spring and summer.
Frequently asked questions
How is COVID-19 monitored in Sweden today?
Folkhälsomyndigheten monitors COVID-19 within its broader respiratory-virus surveillance. The key indicators are laboratory positivity in sampled respiratory cases, hospital admissions for severe acute respiratory infection, ICU admissions, and, in several regions, wastewater detection of SARS-CoV-2. These signals feed both Swedish weekly reports and ECDC's ERVISS.
When do COVID-19 waves occur in Sweden?
Sweden's COVID-19 pattern is less tightly seasonal than flu. Autumn and winter waves are consistent, but summer upticks driven by new variants have also been observed. Folkhälsomyndigheten watches for rising positivity and hospital-admission trends to decide when the situation has shifted from baseline to elevated activity.
How does Sweden compare to other Nordic countries?
Nordic respiratory-virus curves (Sweden, Norway, Finland, Denmark) tend to move broadly in step, with small lead–lag differences driven by travel patterns and school calendars. Because all four countries report into ECDC's ERVISS, their COVID-19 tiers can be read side by side. Sweden often sits close to Denmark in timing.
Is COVID-19 still a concern in Sweden?
For the general adult population with vaccine- or infection-induced immunity, current variants usually cause moderate illness. Risk remains significant for older adults, immunocompromised people, and those with chronic disease. Swedish guidance from Folkhälsomyndigheten continues to recommend seasonal booster doses for risk groups, in line with ECDC and WHO Europe. That targeted approach is what the surveillance system supports.
How should I read COVID-19 activity classifications?
Folkhälsomyndigheten uses qualitative tiers rather than absolute case totals, and ECDC's ERVISS applies equivalent classifications at the European level. A shift from low to moderate or from moderate to high reflects a real change in pressure on healthcare services relative to historical norms. These tiers are deliberately conservative, avoiding false precision that the underlying sample-based data cannot support.
More situation reports
Data last refreshed: Aug 31, 2026, 11:10. Update cadence: weekly.
This page is not medical advice and does not replace consultation with a healthcare professional. For specific symptoms, please contact a medical professional.
About this page
Published by Renderei Martin GmbH, Berlin. No commercial interest in individual health recommendations. The app is optionally monetised via a freemium subscription.
Content is based exclusively on the linked official surveillance publications. Medical statements are curated against the guidance of RKI, ECDC and WHO.
Methodology enquiries: press@infectrisk.com